文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

病理性视网膜新生血管的分子基础:脂质、非编码RNA与细胞串扰的作用

Understanding the Molecular Basis of Pathological Retinal Angiogenesis: Roles of Lipids, Non-Coding RNAs, and Cellular Crosstalk.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本综述聚焦病理性视网膜新生血管这一致盲原因,梳理其作为糖尿病视网膜病变、早产儿视网膜病变、年龄相关性黄斑变性和Coats病等疾病关键临床特征的地位。文章在VEGF、HIF信号与炎症之外,强调脂质介质、非编码RNA以及内皮细胞、周细胞、胶质细胞和视网膜色素上皮细胞等相互串扰在调控病理性新生血管中的作用,并指出超越以VEGF为中心的治疗思路的重要性。

要点

  • 脂质介质与非编码RNA参与病理性视网膜新生血管调控。
  • 内皮细胞、周细胞、胶质细胞与RPE的串扰影响视网膜稳态与异常新生血管。
  • 综述强调超越以VEGF为中心的治疗方向。

核心结论

  • 脂质介质、非编码RNA及多种视网膜细胞间的串扰是病理性视网膜新生血管调控的重要组成,治疗思路不应仅局限于VEGF。

研究设计与样本

  • 本文为综述,围绕病理性视网膜新生血管的分子基础,汇总脂质介质、非编码RNA及视网膜细胞类型参与调控的相关研究。

主要发现

  • 研究者已广泛探讨VEGF信号、HIF信号与炎症在病理性视网膜新生血管调控中的作用。
  • 近期研究显示脂质介质和非编码RNA在视网膜中对病理性新生血管调控具有影响。
  • 内皮细胞、周细胞、胶质细胞和视网膜色素上皮细胞参与病理性新生血管调控,并存在相互串扰。
  • 这些细胞间的相互作用参与维持视网膜稳态,并在DR、AMD、ROP等疾病的异常新生血管中发挥作用。

临床怎么用

  • 解读病理性新生血管机制时应关注VEGF之外脂质介质、非编码RNA与细胞串扰的潜在治疗价值。
  • 针对DR、AMD、ROP等疾病,可关注多细胞类型相互作用而非单一VEGF通路的干预思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pathological retinal neovascularization is a prevalent cause of blindness, impacting millions of individuals across all age groups, from infants to older adults. It is a key clinical feature of several retinal diseases, such as diabetic retinopathy (DR), retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and Coats disease. Researchers have extensively investigated the involvement of vascular endothelial growth factor (VEGF) signaling, hypoxia inducible factor (HIF) signaling, and inflammation in the regulation of pathological retinal neovascularization. Recent breakthroughs have demonstrated the influence of several substances and cells in the retina on the regulation of pathological retinal neovascularization. This review emphasizes the rising significance of substances such as lipid mediators, non-coding ribonucleic acids, as well as the involvement of several retinal cell types, including endothelial cells (ECs), pericytes, glial cells, and the retinal pigment epithelium (RPE) in the regulation of pathological neovascularization. Here, we emphasize the interactions among these cell types in maintaining retinal homeostasis and their role in abnormal neovascularization in diseases like DR, AMD, ROP, etc. This review aims to highlight the importance of molecules and cells that go beyond the VEGF-centric therapeutic focus to treat pathological neovascularization.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sharma A, Kizy S, Singh NK, et al. Understanding the Molecular Basis of Pathological Retinal Angiogenesis: Roles of Lipids, Non-Coding RNAs, and Cellular Crosstalk. Invest Ophthalmol Vis Sci. 2026. PMID: 41837574. doi:10.1167/iovs.67.3.33

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。